Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/14/2025

Management of Hypercalcemia and Magnesium

Electrolyte Management in Critical Care

  • The American Heart Association recommends calcium administration (calcium chloride 10% 5-10 mL or calcium gluconate 10% 15-30 mL IV) in cardiac arrest associated with hypermagnesemia, not magnesium administration 1, 2
  • For cardiac arrest with hypercalcemia, standard ACLS protocols should be followed without specific recommendations for magnesium administration 1, 3

Renal Considerations in Hypercalcemia Management

  • The National Kidney Foundation recommends maintaining calcium levels within the normal range, preferably toward the lower end (8.4 to 9.5 mg/dL), in patients with chronic kidney disease 4
  • Calcium-based phosphate binders should not be used in dialysis patients who are hypercalcemic (corrected serum calcium >10.2 mg/dL) 4

Potential Risks of Inappropriate Management

  • Excessive magnesium supplementation can lead to hypermagnesemia with symptoms including muscular weakness, paralysis, ataxia, drowsiness, confusion, and in severe cases, cardiac arrhythmias and cardiorespiratory arrest 1, 3